Ken Griffin Amerisourcebergen Corp Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	N/A	-26,800 Reduced 6.47%	387,200 $71.7 Million
Q1 2024 May 15, 2024	SELL	N/A	-394,000 Reduced 48.76%	414,000 $76.7 Million
Q4 2023 Feb 14, 2024	BUY	$179.08 - $189.89 $12.5 Million - $13.3 Million	69,800 Added 9.46%	808,000 $150 Million
Q3 2023 Nov 14, 2023	BUY	$172.87 - $193.41 $107 Million - $120 Million	619,200 Added 520.34%	738,200 $133 Million
Q2 2023 Aug 14, 2023	BUY	$162.28 - $192.43 $6.47 Million - $7.68 Million	39,900 Added 50.44%	119,000 $22.9 Million
Q1 2023 May 15, 2023	SELL	$148.37 - $168.96 $15.8 Million - $18 Million	-106,600 Reduced 57.4%	79,100 $12.7 Million
Q4 2022 Feb 14, 2023	SELL	$137.35 - $173.99 $8.42 Million - $10.7 Million	-61,300 Reduced 24.82%	185,700 $30.8 Million
Q3 2022 Nov 14, 2022	BUY	$135.33 - $152.66 $1 Million - $1.13 Million	7,400 Added 3.09%	247,000 $33.4 Million

1,222

168M

4.99M

5.21M

Ticker ABC
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 207,258,000
Market Cap $38.4B
Description
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, inc...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.